Bill Meagher

Bill Meagher's focus with The Deal is on small and microcap equity finance, SEC regulation, PIPEs and the controversial world of reverse mergers and penny stocks. His work has appeared in newspapers and magazines throughout California as well as on PBS, “60 Minutes,” ABC News and CNBC. Meagher has also written video scripts and produced national events for a non-profit educational organization.

Recent Articles By The Author

Family Offices Start Taking the Look of Financial Sponsors

Family Offices Start Taking the Look of Financial Sponsors

Long the bastion of the fabulously rich, these firms are no longer letting others do their bidding and are instead directly investing in portfolio companies themselves.

Why Rupert Murdoch Will Survive the Fox scandal

Why Rupert Murdoch Will Survive the Fox scandal

Sexual harassment allegations at Fox News have hurt the value of Twenty-First Century Fox, but its governance keeps the Murdoch family that controls it beyond the reach of investor outrage.

Another Way to Invest With the Smart Money: SPACs

Another Way to Invest With the Smart Money: SPACs

Once a shaky alternative to conventional IPOs, special-purpose acquisition companies let the public in on private equity bets.

Reverse Mergers Losing Out to Lower-Cost Offerings

Reverse Mergers Losing Out to Lower-Cost Offerings

Regulation A+ and self-underwritten offerings may be the vehicles of choice for companies that can't afford a traditional IPO.

How Martin Shkreli Defended His Biotech Shorting Scheme

How Martin Shkreli Defended His Biotech Shorting Scheme

In this interview with The Deal's Bill Meagher, first posted on Jan. 17, 2013, Shkreli defends his drug business and his shorting strategy.